Literature DB >> 6211075

Coronary hemodynamics during percutaneous transluminal coronary angioplasty.

M T Rothman, D S Baim, J B Simpson, D C Harrison.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6211075     DOI: 10.1016/0002-9149(82)90236-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

1.  Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction.

Authors:  M K Sinha; J M Vazquez; R Calvino; D C Gaze; P O Collinson; J C Kaski
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

Review 2.  Physiological aspects of percutaneous transluminal coronary angioplasty.

Authors:  H Kline
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

3.  Coronary sinus potassium concentration recorded during coronary angioplasty.

Authors:  S C Webb; A F Rickards; P A Poole-Wilson
Journal:  Br Heart J       Date:  1983-08

4.  Endothelium dependent and independent responses in coronary artery disease measured at angioplasty.

Authors:  D R Holdright; D Clarke; P A Poole-Wilson; K Fox; P Collins
Journal:  Br Heart J       Date:  1993-07

Review 5.  Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.

Authors:  Lavanya Athithan; Gaurav S Gulsin; Gerald P McCann; Eylem Levelt
Journal:  World J Diabetes       Date:  2019-10-15

6.  Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes.

Authors:  Sharmaine Thirunavukarasu; Nicholas Jex; Amrit Chowdhary; Imtiaz Ul Hassan; Sam Straw; Thomas P Craven; Miroslawa Gorecka; David Broadbent; Peter Swoboda; Klaus K Witte; Richard M Cubbon; Hui Xue; Peter Kellman; John P Greenwood; Sven Plein; Eylem Levelt
Journal:  Diabetes       Date:  2021-10-05       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.